MGMichael Graz

Michael Graz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael Graz has a total of 62 co-authors. Here are the top co-authors by number of shared publications:

  • Achim Hoerauf

    German Center for Infection Research (DZIF), Braunschweig, Germany

    1 shared publication
  • Ahmet Can Mert

    Graz University of Technology

    1 shared publication
  • Alastair Baker

    School of Chemical and Process Engineering, University of Leeds, Leeds LS2 9JT, UK

    1 shared publication
  • Alexander Titz

    Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research, Saarbrücken, D-66123, Germany; Deutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-Braunschweig, Germany; Department of Chemistry, PharmaScienceHub (PSH), Saarland University, Saarbrücken, D-66123, Germany

    1 shared publication
  • Anders Karlén

    Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden

    1 shared publication
  • Andrea Schiefer

    Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, University of Bonn, Bonn, Germany

    1 shared publication

Latest Publications

  • Open Access

    Whipping the Multivariate-based MAYO Signature Scheme using Hardware Platforms

    by Florian Hirner, Michael Streibl, Florian Krieger, Ahmet Can Mert, Sujoy Sinha Roy

    NIST issued a new call in 2023 to diversify the portfolio of quantum-resistant digital signature schemes since the current portfolio relies on lattice problems. The MAYO scheme, which builds on the Unbalanced Oil and Vinegar (UOV) problem, is a promising candidate for this new call. MAYO introduces emulsifier maps and a novel 'whipping' technique to significantly reduce the key sizes compared to previous UOV schemes. This paper provides a comprehensive analysis of the implementation aspects of MAYO and proposes several optimization techniques that we use to implement a high-speed hardware accelerator. The first optimization technique is the partial unrolling of the emulsification process to increase parallelization. The second proposed optimization is a novel memory structure enabling the parallelization of significant bottlenecks in the MAYO scheme. In addition to this, we present a flexible transposing technique for the data format used in MAYO that can be expanded to other UOV-based schemes. We use these techniques to design the first high-speed ASIC and FPGA accelerator that supports all operations of the MAYO scheme for different NIST security levels. Compared with state-of-the-art, like HaMAYO [24] and UOV [7], our FPGA design shows a performance benefit of up to three orders of magnitude in both latency and area-time-product. Furthermore, we lower the BRAM consumption by up to 2.8 × compared to these FPGA implementations. Compared to high-end CPU implementations, our ASIC design allows between 2.81× and 60.14× higher throughputs. This increases the number of signing operations per second from 483 to 13424, thereby fostering performant deployment of the MAYO scheme in time-critical applications.


  • Top Cited Papers

    Towards the sustainable discovery and development of new antibiotics

    by Marcus Miethke, Marco Pieroni, Tilmann Weber, Mark Brönstrup, Peter Hammann, Ludovic Halby, Paola B. Arimondo, Philippe Glaser, Bertrand Aigle, Helge B. Bode, et al.

    An ever-increasing demand for novel antimicrobials to treat life-threatening infections caused by the global spread of multidrug-resistant bacterial pathogens stands in stark contrast to the current level of investment in their development, particularly in the fields of natural-product-derived and synthetic small molecules. New agents displaying innovative chemistry and modes of action are desperately needed worldwide to tackle the public health menace posed by antimicrobial resistance. Here, our consortium presents a strategic blueprint to substantially improve our ability to discover and develop new antibiotics. We propose both short-term and long-term solutions to overcome the most urgent limitations in the various sectors of research and funding, aiming to bridge the gap between academic, industrial and political stakeholders, and to unite interdisciplinary expertise in order to efficiently fuel the translational pipeline for the benefit of future generations.


  • Flow Synthesis of Symmetrical Di- and Trisulfides Using Phase-Transfer Catalysis

    by Alastair Baker, Michael Graz, Robert Saunders, Gareth J. S. Evans, Sandra Kaul, Thomas Wirth

    Using mild conditions and short reaction times, symmetrical disulfides have been synthesized in flow chemistry using phase transfer catalysts to facilitate the substitution of organohalides with disodium disulfide. Also, the synthesis of symmetrical trisulfides was possible using this procedure with an additional equivalent of sulfur.